ATADvantage TherapeuticsADvantage Therapeutics is a pharmaceutical company that develops therapeutics for patients suffering from neurodegenerative disease. It specializes in developing therapies to treat Alzheimer's Disease and potentially paradigm-changing therapies.
Biopharma
MIA
2021
$21M
CTCadrenal TherapeuticsCadrenal Therapeutics is a biopharmaceutical company developing a late-stage novel therapy for patients with end-stage renal disease and atrial fibrillation. The company was founded in 2022 and is headquartered in Ponte Vedra Beach, Florida.
Biopharma
JAX
2022
$20M
ETEnalare TherapeuticsEnalare Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapies for patients suffering from acute respiratory and critical care conditions including respiratory depression caused by drug overdose, post-surgery, and pathogens.
Biopharma
SWFL
2019
$76M
HAHalodineHalodine is a biopharmaceutical company focused on the development of novel antiviral therapies. Halodine is a proprietary povidone-iodine antiseptic developed by leading clinicians for repeated nasal and oral administration. Halodine Nasal Antiseptic and Halodine Oral Rinse have been proven effective against SARS-CoV-2, the virus causing COVID-19, as well as other infections. Safe and easy-to-use, Halodine is designed to help protect hospitalized patients, health care personnel, and consumers. It was founded and is led by practicing MDs. Founded in 2020, the company is based in Miami, Florida.
Biopharma
MIA
2020
$2.3M
KBKincell BioKincell Bio collaborates with cell therapy developers by using considerable scientific experience and industry understanding. Transparency, accountability, and accuracy are essential to what makes us a reliable partner for process and analytical development, CMC assistance, and high-quality clinical cell therapy manufacturing services.